Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

FRA/2B4 stock hub

FRA/2B4 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/2B4is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/2B4

In the news

Latest news · FRA/2B4

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E42.6

P25 12.3P50 15.7P75 20.2

Trailing P/E82.2

P25 16.4P50 20.9P75 30.4

ROE22

P25 -6.7P50 8.5P75 17.2

ROIC46.6

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/2B4 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

SEK

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	DE
Employees	160
Employees Change	12%
Employees Change Percent	9.16
Enterprise value	EUR 1.3B
Exchange	Frankfurt Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	SE0009858152
Last refreshed	2026-05-10
Market cap	EUR 1.4B
Price	EUR 21.26
Price currency	EUR
Rev Per Employee	692,128.23x
Sector	Healthcare
Sic	3842
Symbol	fra/2B4
Website	https://www.bonesupport.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.22%
EV Earnings	79.8x
EV/EBIT	45.66x
EV/EBITDA	44.26x
EV/FCF	59.81x
EV/Sales	12.03x
FCF yield	1.62%
Forward P/E	42.61x
P/B ratio	16.21x
P/E ratio	82.21x
P/S ratio	12.52x
PE Ratio3 Y	107.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.34%
EBITDA Margin	26.51%
FCF margin	20.32%
Gross margin	92.48%
Gross Profit	EUR 102.4M
Gross Profit Growth	21.61%
Gross Profit Growth Q	13.85%
Gross Profit Growth3 Y	48.09%
Gross Profit Growth5 Y	47.16%
Net Income	EUR 16.9M
Net Income Growth	51.31%
Net Income Growth Q	411.94%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	20.94%
Profit Margin	15.23%
Profit Per Employee	EUR 105,435
Profitable Years	3
ROA	19.86
Roa5y	1.57
ROCE	33.86
ROE	22.04
Roe5y	9.56
ROIC	46.63
Roic5y	-26.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.42%
Cagr3y	33.77%
Cagr5y	23.74%
EPS Growth	50.66
EPS Growth Q	405.3
EPS Growth Quarters	1
EPS Growth Years	1
FCF Growth	162.51%
FCF Growth Q	60.76%
OCF Growth	161.56%
OCF Growth Q	60.7%
Revenue Growth	21.78x
Revenue Growth Q	14.28x
Revenue Growth Quarters	23x
Revenue Growth Years	7x
Revenue Growth3 Y	47.04x
Revenue Growth5 Y	46.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.21
Assets	EUR 102M
Cash	EUR 41.5M
Current Assets	EUR 81.9M
Current Liabilities	EUR 16M
Debt	EUR 1.3M
Debt EBITDA	EUR 0.04
Debt Equity	EUR 0.02
Debt FCF	EUR 0.06
Equity	EUR 85.6M
Interest Coverage	11.85
Liabilities	EUR 16.4M
Long Term Assets	EUR 20M
Long Term Liabilities	EUR 432,306
Net Cash	EUR 40.2M
Net Cash By Market Cap	EUR 2.9
Net Cash Growth	73.36%
Net Debt EBITDA	EUR -1.37
Net Debt Equity	EUR -0.47
Net Debt FCF	EUR -1.79
Tangible Book Value	EUR 84.2M
Tangible Book Value Per Share	EUR 1.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.13
Inventory Turnover	0.65
Net Working Capital	EUR 24.6M
Quick ratio	3.9
Working Capital	EUR 65.3M
Working Capital Turnover	EUR 0.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.41%
200-day SMA	21.33
3Y total return	139.41%
50-day SMA	19.78
50-day SMA vs 200-day SMA	50under200
5Y total return	190.04%
All Time High	39.42
All Time High Change	-46.07%
All Time High Date	2025-01-06
All Time Low	0.87
All Time Low Change	2,332.49%
All Time Low Date	2018-06-25
ATR	0.77
Ch YTD	22.89
High	21.26
High52	30.66
High52 Date	2025-07-30
High52ch	-30.66%
Low	20.98
Low52	15.5
Low52 Date	2026-02-24
Low52ch	37.16%
Ma50ch	7.47%
Price vs 200-day SMA	-0.33%
RSI	51.67
RSI Monthly	49.62
RSI Weekly	52.54
Sharpe ratio	-0.24x
Sortino ratio	-0.27
Total Return	-0.12%
Tr YTD	22.89
Tr1m	5.88%
Tr1w	-1.12%
Tr3m	32.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 29.2M
Operating Income Growth	120.6
Operating Income Growth Q	143.4
Operating margin	26.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,006,379%
Net Borrowing	-620,258
Shares Insiders	10.33%
Shares Institutions	44.38%
Shares Qo Q	-0%
Shares Yo Y	0.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 19.7M
Average Volume	134.3x
Bv Per Share	1.3
CAPEX	EUR -239,591
Ch1m	5.88
Ch1w	-1.12
Ch1y	-22.41
Ch3m	32.13
Ch3y	139.4
Ch5y	190
Ch6m	21.21
Change	-0.56%
Change From Open	1.24
Close	21.38
Days Gap	-1.78
Depreciation Amortization	194,446
Dollar Volume	2,551.2
Earnings Date	2026-04-22
EBIT	EUR 29.2M
EBITDA	EUR 29.4M
EPS	EUR 0.25
F Score	5
FCF	EUR 22.5M
FCF EV Yield	1.67x
Financing CF	-5,117,992
Fiscal Year End	December
Founded	1,999
Graham Number	2.76266
Graham Upside	-87.01
Income Tax	EUR 6.3M
Investing CF	-497,500
Is Primary Listing	0
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Ma150	19.23
Ma150ch	10.58%
Ma20	22.12
Ma20ch	-3.88%
Net CF	17,144,576
Next Earnings Date	2026-07-16
Open	21
P FCF Ratio	61.62
P OCF Ratio	60.97
Position In Range	100
Ppne	1,898,315.3
Price Date	2026-05-08
Price EBITDA	EUR 47.23
Ptbv Ratio	16.47
Relative Volume	0.89x
Revenue	110,740,517x
SBC By Revenue	2.58x
Share Based Comp	2,853,313
Tax By Revenue	5.71x
Tax Rate	27.25%
Tr6m	21.21%
Volume	120
Z Score	56.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/2B4 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2B4 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/2B4?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.4%

Share of float held by funds and institutions

Insider ownership

+10.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/2B4 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.7

Neutral momentum band

Price vs 200-day MA

-0.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/2B4

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2B4 stock rating?

fra/2B4 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2B4 analysis?

The full report lives at /stocks/fra/2B4/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2B4?

The latest report frames fra/2B4 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2B4 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.